Skip to main content

Advertisement

SpringerLink
Log in

Novel four-way Ph translocation t(9;22;7;1)(q34;q11;q22;p13) in a chronic myeloid leukemia patient receiving tyrosine kinase inhibitor therapy

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

The occurrence of a four-way Philadelphia chromosome translocation is a very rare event in myeloid malignancies, and the phenotypic consequences of such rearrangements remain to be investigated. We describe a case of a chronic myeloid leukemia (CML) patient with a complex four-way t(9;22;7,1) translocation who received multiple tyrosine kinase inhibitor therapy. As evaluation of prognostic features in a limited number of patients with four-way Philadelphia rearrangements at present yields controversial results, our case may add further information on the prognostic impact of such abnormalities in CML patients receiving tyrosine kinase inhibitor therapy, and may help delineate a sub-group of patients requiring different therapeutic approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Bennour A, Sennana H, Laatiri MA, Elloumi M, Khelif A, Saad A. Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9. Cancer Genet Cytogenet. 2009;194:30–7.

    Article  PubMed  CAS  Google Scholar 

  2. Giere I, Migliorini AM, Bengio R, Arias D, Slavutsky I, Larripa I. Cytogenetic and molecular studies of variant Ph′ translocations. Haematologica. 2000;85:435–7.

    PubMed  CAS  Google Scholar 

  3. Shaffer LG, Slovak ML, Campbell LJ. ISCN. International System of Human Cytogenetic Nomenclature. Basel: S Karger AG; 2009.

  4. Reid AG, Huntly BJ, Grace C, Green AR, Nacheva EP. Survival implications of molecular heterogeneity in variant Philadelphia-positive chronic myeloid leukaemia. Br J Haematol. 2003;121:419–27.

    Article  PubMed  Google Scholar 

  5. El-Zimaity MMT, Kantarjian H, Talpaz M, O’Brien S, Giles F, et al. Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome. Br J Haematol. 2004;125:187–95.

    Article  PubMed  CAS  Google Scholar 

  6. Marzocchi G, Castagnetti F, Luatti S, Baldazzi C, Stacchini M, Gugliotta G, et al. Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis. Blood. 2011;117:6793–800.

    Article  PubMed  CAS  Google Scholar 

  7. Okada M, Satake A, Kaida K, Taniguchi K, Yoshihara S, Ikegame K, et al. Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene. Int J Hematol. 2011;93:243–6.

    Article  PubMed  Google Scholar 

  8. Fitzgerald PH, Morris CM. Complex chromosomal translocations in the Philadelphia chromosome leukemias. Serial translocations or a concerted genomic rearrangement? Cancer Genet Cytogenet. 1991;57:143–51.

    Article  PubMed  CAS  Google Scholar 

  9. Gorusu M, Benn P, Li Z, Fang M. On the genesis and prognosis of variant translocations in chronic myeloid leukemia. Cancer Genet Cytogenet. 2007;173:97–106.

    Article  PubMed  CAS  Google Scholar 

  10. Fundia AF, Acevedo SH, Larripa IB. Chromosomal instability in chronic myeloid leukemia: Philadelphia breakpoints are irrespective to spontaneous breakage and fragile sites. Haematologica. 2000;85:1104–6.

    PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Laboratory of Cancer Genetics, Department of Hematology, Kuwait Cancer Control Center, PO Box 42262, 70653, Kuwait, Kuwait

    Zámečníkova Adriana & Soad Al Bahar

Authors
  1. Zámečníkova Adriana
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Soad Al Bahar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zámečníkova Adriana.

About this article

Cite this article

Adriana, Z., Al Bahar, S. Novel four-way Ph translocation t(9;22;7;1)(q34;q11;q22;p13) in a chronic myeloid leukemia patient receiving tyrosine kinase inhibitor therapy. Int J Hematol 95, 315–319 (2012). https://doi.org/10.1007/s12185-012-1018-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-012-1018-9

Keywords

Search

Navigation